PWA
MRK icon

Providence Wealth Advisors’s Merck MRK Stock Holding History

Providence Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
11,036
-92
-0.8% -$10.8K 0.84% 40
2026
Q1 		$1.35M Buy
11,128
+199
+2% +$23K 0.86% 40
2025
Q4 		$1.16M Sell
10,929
-200
-2% -$18.8K 0.73% 44
2025
Q3 		$969K Buy
11,129
+215
+2% +$17.7K 0.61% 46
2025
Q2 		$875K Sell
10,914
-81
-0.7% -$6.44K 0.6% 48
2025
Q1 		$956K Buy
10,995
+617
+6% +$57.6K 0.72% 45
2024
Q4 		$1.04M Sell
10,378
-66
-0.6% -$6.8K 0.78% 44
2024
Q3 		$1.11M Buy
10,444
+290
+3% +$34.5K 0.82% 41
2024
Q2 		$1.31M Buy
10,154
+280
+3% +$36.1K 1.04% 32
2024
Q1 		$1.29M Buy
9,874
+302
+3% +$37.2K 1.1% 31
2023
Q4 		$1.22M Buy
9,572
+511
+6% +$53K 1.1% 28
2023
Q3 		$924K Buy
9,061
+175
+2% +$18.9K 1.03% 32
2023
Q2 		$1.01M Sell
8,886
-825
-8% -$93.7K 1.12% 30
2023
Q1 		$1.11M Buy
9,711
+96
+1% +$10.4K 0.82% 41
2022
Q4 		$1.09M Buy
9,615
+125
+1% +$12.8K 0.81% 40
2022
Q3 		$976K Sell
9,490
-173
-2% -$15.4K 0.73% 44
2022
Q2 		$901K Buy
9,663
+923
+11% +$81.8K 0.65% 49
2022
Q1 		$730K Buy
8,740
+215
+3% +$17K 0.47% 62
2021
Q4 		$685K Hold
8,525
– – 0.43% 67
2021
Q3 		$703K Buy
8,525
+300
+4% +$22.8K 0.49% 59
2021
Q2 		$643K Buy
8,225
+66
+0.8% +$4.91K 0.44% 62
2021
Q1 		$600K Buy
8,159
+1,268
+18% +$93.5K 0.44% 63
2020
Q4 		$530K Buy
6,891
+809
+13% +$61.9K 0.44% 62
2020
Q3 		$481K Buy
6,082
+2,618
+76% +$205K 0.48% 60
2020
Q2 		$256K Buy
+3,464
New +$261K 0.26% 80
2019
Q2 		– Sell
-2,568
Closed -$205K – 83
2019
Q1 		$205K Buy
+2,568
New +$192K 0.19% 83

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Providence Wealth Advisors's MRK Position: Q2 2026 in Review

Providence Wealth Advisors reduced its Merck (MRK) stake by 0.83% in Q2 2026, selling an estimated $10.8K and leaving 11,036 shares worth $1.42M. The position accounts for 0.84% of the portfolio, ranked #40.

Providence Wealth Advisors first reported a position in MRK in Q1 2019 and has held it in 26 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Providence Wealth Advisors held 11,036 shares of Merck worth $1.42M as of Q2 2026.
  • Providence Wealth Advisors sold 92 Merck shares in Q2 2026, an estimated $10.8K.
  • Merck made up 0.84% of Providence Wealth Advisors's portfolio in Q2 2026, its #40 holding.
  • Providence Wealth Advisors first reported a position in Merck in Q1 2019 and has held it in 26 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Providence Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.